Study Details
Full Title
BCC022: Phase II Trial of Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
Principal Investigator
Jessica
Sun
Protocol Number
PRO00118933
NCT ID
NCT06540963
Phase
II
Enrollment Status
Open to Enrollment